Clinical Trial Update: First-in-man Sirolimus-eluting Prolim® Stent Registry [NA]

View source ↗

Summary

A first-in-man registry evaluating the sirolimus-eluting Prolim stent in coronary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland | Conditions: Sirolimus-eluting Stainless Steel Coronary Stent Prolim® | NA | Status: COMPLETED